Premium
Polymorphonuclear leukocytes from patients with severe sepsis have lost the ability to degrade fibrin via u‐PA
Author(s) -
Moir E.,
Greaves M.,
Adey G. D.,
Bennett B.
Publication year - 2004
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.0502257
Subject(s) - fibrin , sepsis , immunology , septic shock , biology , lysis , plasminogen activator , antigen , fibrinolysis , urokinase , medicine , endocrinology , genetics
Fibrin persistence in the vasculature is an important complication of sepsis that can often lead to mortality. We have previously established that polymorphonuclear leukocytes (PMN) from healthy individuals have the capacity to degrade fibrin via urokinase‐type plaminogen activator (u‐PA). We have also demonstrated an increase in u‐PA antigen in the plasma of patients suffering from septic shock. In this study, we investigate the hypothesis that PMN from patients with sepsis have lost their fibrinolytic ability and that this might contribute to the persistence of fibrin deposits We show here that PMN from these patients do not express any u‐PA activity, despite retaining some u‐PA antigen. Additionally, thrombi prepared from the whole blood of the patients exhibit reduced endogenous lysis compared with those from healthy individuals. These data indicate that loss of fibrinolytic activity from PMN may be a contributing factor in fibrin persistence in the microvasculature in sepsis.